```
Miller Group, conference room.
Shirley Miller concluded her presentation, summarizing, "For the company to develop and break through the bottleneck, investing in new industries and finding new profit sources is absolutely necessary. I hope everyone can support this investment."
Shareholder Alexis Vasquez chuckled, "Acquiring the Seacoast Pharmaceutical Company is going to cost a pretty penny. Our company's books don't have that kind of funds, and taking a loan would be a huge risk."
Shareholder Rusty Schneider echoed, "Right, it's got to be at least two hundred million in loans, which would put a huge burden on the company. Our current business is growing steadily; why the rush? If we overreach, we're going to end up in trouble."
The room burst into laughter, the sound light and frivolous.
Shirley Miller's face remained cold, her mood indignant.
A group of short-sighted shareholders, more trouble than they're worth—can such an enterprise really have a future?
